Novum Pharmaceutical Research Services   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Pittsburgh PA United States (1972)
Status: Acquired by Lambda Therapeutic Research Ltd (2019)

Organization Overview

First Clinical Trial
1993
NCT00947024
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

http://www.novumprs.com/contact | Novum | Novum Independent Institutional Review Board | Novum Pharmaceutical Research Services | Novum Pharmaceutical Research Services, 3320 Walnut Bend Lane, Honston, Texas 77042-4712, USA | Novum Pharmaceutical Research Services, 3320 Walnut Bend Lane, Houston, Texas 77042-4712, United States of America (USA) | Novum Pharmaceutical Research Services, 5900 Penn Avenue, Pittsburgh, PA 15206-3817 | Novum Pharmaceutical Reserach Services | Novum Pharmaceuticals Research Services

Active Ingredients

Drugs in Phase 4 Trials (1)

desoximetasone (topicort) (13 trials)

Drugs in Phase 3 Trials (11)

azelastine (astelin) (1 trial)

ciprofloxacin (cipro) (4 trials)

diclofenac (voltaren) (2 trials)

endoxifen (1 trial)

estradiol (progynon depot) (1 trial)

fluticasone (cutivate) (1 trial)

ketoconazole (nizoral) (2 trials)

lubiprostone (amitiza) (1 trial)

mometasone (elocon) (1 trial)

permethrin (nix) (2 trials)

urea (2 trials)

Drugs in Phase 2 Trials (3)

auriclosene (1 trial)

halobetasol (ultravate) (2 trials)

novexatin (1 trial)

Drugs in Phase 1 Trials (31)

bleomycin (blenoxane) (1 trial)

bupropion (wellbutrin) (2 trials)

cefdinir (omnicef) (2 trials)

cetirizine (zyrtec) (2 trials)

cevimeline hydrochloride (evoxac) (2 trials)

clarithromycin (biaxin) (2 trials)

clobetasol (dermovate) (2 trials)

colchicine (colbenemid) (2 trials)

didanosine (videx) (1 trial)

doxorubicin (Doxil) (1 trial)

fentanyl (Innovar) (1 trial)

finasteride (Proscar) (4 trials)

glimepiride (amaryl) (2 trials)

glipizide (glucotrol) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

leflunomide (arava) (3 trials)

mesalamine (rowasa) (1 trial)

metronidazole (flagyl) (1 trial)

moexipril (univasc) (2 trials)

ondansetron (zofran) (4 trials)

oxymorphone (opana) (3 trials)

ribavirin (virazole) (2 trials)

risperidone (risperdal) (2 trials)

ropinirole (Requip) (2 trials)

sitagliptin (januvia) (2 trials)

terbinafine (lamisil) (2 trials)

tinidazole (tindamax) (1 trial)

vincristine (oncovin) (1 trial)

zalcitabine (hivid) (1 trial)

zaleplon (sonata) (4 trials)

zolpidem (ambien) (2 trials)

Drugs in Other Trials (5)

balsalazide (colazal) (2 trials)

imipramine (tofranil) (1 trial)

levetiracetam (keppra) (2 trials)

lithium (lithonate) (2 trials)

meloxicam (mobic) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Arthritis, Psoriatic (Phase 1)

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Constipation (Phase 3)

Depression (Phase 1)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Diabetes Mellitus, Type 2 (Phase 1)

Disease (Phase 3)

Eczema (Phase 3)

Impetigo (Phase 2)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Malnutrition (Phase 1)

Onychomycosis (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Otitis (Phase 3)

Otitis Externa (Phase 3)

Otitis Media (Phase 3)

Psoriasis (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Sarcoma (Phase 1)

Sarcoma, Kaposi (Phase 1)

Scabies (Phase 3)

Signs and Symptoms (Phase 3)

Tinea (Phase 3)

Tinea Pedis (Phase 3)

Trichomonas Infections (Phase 1)

Vaginitis (Phase 3)

Vomiting (Phase 1)

Xerostomia (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 95
  • # of Trial APIs: 51